ATLANTA, GA--(Marketwired - Feb 8, 2016) - Innovative Holdings Alliance, Inc. (Innovative), (OTC PINK: IHAI) is pleased to announce a Joint Venture Agreement with Synaptic OTC Sciences, a Colorado LLC. (Synaptic).
Innovative and Synaptic have completed an Agreement that is mutually beneficial and in the best interest of our shareholders. Throughout 2015, Innovative researched many different opportunities and made significant inroads to implement our growth initiatives and contingencies.
The Company's initial focus will be on commissioning the development of nutraceutical products and therapies aimed at providing relief for a number of diverse ailments and maladies, including but not limited to chronic pain, sleep disorders, depression, Post-Traumatic Stress Disorder (PTSD) and Social Anxiety Disorders (SAD).
Through this new alliance, Innovative will be providing our managerial, financial and marketing expertise for licensing a line of clinically tested, science- backed and branded medical cannabidiol (CBD) and hemp products. Our incipient products will focus on chronic pain, defined as pain that persists longer than a month or two. Recent studies, published by The Institute of Medicine and The Journal of Pain to name a few, show that the total costs related to chronic pain ranged from $560 to $635 billion dollars a year. In a July 2015 NIH publication discussing Cannabinoids as medicine, "NIH-funded and other researchers are continuing to explore the possible uses of THC, CBD and other cannabinoids for medical treatment."
"We are extremely pleased to be moving forward with exciting new products that will benefit so many people in so many ways. We expect to launch our initial line of licensed products in the coming four to six months. We feel like it is a way of building a successful Company while also giving back to so many in need," said Chris Winter, President of Innovative.
Innovative's marketing materials and website are currently being updated to reflect these exciting developments regarding our new ventures.
Innovative Holdings Alliance, Inc. has embraced, as its corporate mission, a plan to acquire interests in and partner with companies that are leading edge in their respective market niches, and that have expectations of enhancing shareholder values.
This press release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involved risks, uncertainties and other factors, which may cause the actual results, performance or achievements of the Company to be materially different from the statements made herein. Statements contained in this news release, other than those identifying historical facts, constitute "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934 and Safe Harbor provisions as contained in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relating to the company's future expectations, including but not limited to revenues and earnings, technology efficacy, strategies and plans, are subject to safe harbors protection. Actual Company results and performance may be materially different from any future results, performance, strategies, plans or achievements that may be expressed or implied by any such forward-looking statements. The Company disclaims any obligation to update or revise any forward-looking statements.